201 related articles for article (PubMed ID: 25310972)
1. CD8+ T-cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulation.
Zhang W; Zhang C; Li W; Deng J; Herrmann A; Priceman SJ; Liang W; Shen S; Pal SK; Hoon DSB; Yu H
Eur J Immunol; 2015 Jan; 45(1):71-81. PubMed ID: 25310972
[TBL] [Abstract][Full Text] [Related]
2. Silence STAT3 in the procancer niche… and activate CD8+ T cells to kill premetastatic myeloid intruders.
Auphan-Anezin N; Schmitt-Verhulst AM
Eur J Immunol; 2015 Jan; 45(1):44-8. PubMed ID: 25471823
[TBL] [Abstract][Full Text] [Related]
3. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes.
Lu C; Klement JD; Ibrahim ML; Xiao W; Redd PS; Nayak-Kapoor A; Zhou G; Liu K
J Immunother Cancer; 2019 Jun; 7(1):157. PubMed ID: 31228946
[TBL] [Abstract][Full Text] [Related]
6. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.
Deng J; Liu Y; Lee H; Herrmann A; Zhang W; Zhang C; Shen S; Priceman SJ; Kujawski M; Pal SK; Raubitschek A; Hoon DSB; Forman S; Figlin RA; Liu J; Jove R; Yu H
Cancer Cell; 2012 May; 21(5):642-654. PubMed ID: 22624714
[TBL] [Abstract][Full Text] [Related]
7. Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.
Herrmann A; Kortylewski M; Kujawski M; Zhang C; Reckamp K; Armstrong B; Wang L; Kowolik C; Deng J; Figlin R; Yu H
Cancer Res; 2010 Oct; 70(19):7455-64. PubMed ID: 20841481
[TBL] [Abstract][Full Text] [Related]
8. Photosensitizer and Light Pave the Way for Cytosolic Targeting and Generation of Cytosolic CD8 T Cells Using PLGA Vaccine Particles.
Bruno C; Waeckerle-Men Y; Håkerud M; Kündig TM; Gander B; Johansen P
J Immunol; 2015 Jul; 195(1):166-73. PubMed ID: 26019274
[TBL] [Abstract][Full Text] [Related]
9. IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung.
Jing B; Wang T; Sun B; Xu J; Xu D; Liao Y; Song H; Guo W; Li K; Hu M; Zhang S; Ling J; Kuang Y; Zhang T; Zhou BP; Yao F; Deng J
Cancer Res; 2020 Feb; 80(4):784-797. PubMed ID: 31848193
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
Winter H; Hu HM; McClain K; Urba WJ; Fox BA
J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
[TBL] [Abstract][Full Text] [Related]
11. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner.
Yu R; Jin L; Li F; Fujimoto M; Wei Q; Lin Z; Ren X; Jin Q; Li H; Meng F; Jin G
J Dermatol Sci; 2020 Sep; 99(3):193-202. PubMed ID: 32859456
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
[TBL] [Abstract][Full Text] [Related]
14. Mouse CD8
Li Z; Wu Y; Wang C; Zhang M
Cancer Immunol Immunother; 2019 Aug; 68(8):1303-1315. PubMed ID: 31278476
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
[TBL] [Abstract][Full Text] [Related]
17. Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells.
Kato Y; Yoshino I; Egusa C; Maeda T; Pili R; Tsuboi R
J Dermatol Sci; 2014 Aug; 75(2):140-7. PubMed ID: 24866536
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation.
Kimura T; Sugaya M; Oka T; Blauvelt A; Okochi H; Sato S
Oncotarget; 2015 Jul; 6(20):18081-93. PubMed ID: 26098776
[TBL] [Abstract][Full Text] [Related]
19. Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3.
Brayer J; Cheng F; Wang H; Horna P; Vicente-Suarez I; Pinilla-Ibarz J; Sotomayor EM
Immunol Lett; 2010 Jul; 131(2):126-30. PubMed ID: 20346983
[TBL] [Abstract][Full Text] [Related]
20. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.
Yue C; Shen S; Deng J; Priceman SJ; Li W; Huang A; Yu H
Cancer Immunol Res; 2015 Aug; 3(8):864-870. PubMed ID: 26025380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
